Acrivon Therapeutics, Inc. short interest in 2026
In 2026, Acrivon Therapeutics, Inc.'s disclosed short interest ran from 23.83% of shares outstanding on 15 Jan 2026 to 2.81% on 15 Sep 2026, a change of -21.02 percentage points. The year's high was 23.83% on 15 Jan 2026 and its low 2.66% on 31 Aug 2026, averaging 6.61% across 13 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 8.16 days on 15 Jun 2026. Full history: Acrivon Therapeutics, Inc..
Cite this page
By year: 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 23.83% (15 Jan 2026)
- End of year
- 2.81% (15 Sep 2026)
- Change
- -21.02 pp
- High
- 23.83% (15 Jan 2026)
- Low
- 2.66% (31 Aug 2026)
- Average
- 6.61%
- Highest days to cover
- 8.16 (15 Jun 2026)
- SEC filings marked
- 7
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 23.83% | 1.30 | results (8-K) |
| 31 Mar 2026 | 5.64% | 3.42 | 10-K filed, results (8-K) |
| 15 Apr 2026 | 6.16% | 4.16 | |
| 30 Apr 2026 | 6.36% | 2.29 | |
| 15 May 2026 | 6.44% | 4.43 | 10-Q filed, results (8-K) |
| 29 May 2026 | 7.23% | 6.07 | |
| 15 Jun 2026 | 7.30% | 8.16 | |
| 30 Jun 2026 | 7.33% | 7.58 | |
| 15 Jul 2026 | 3.84% | 2.34 | |
| 31 Jul 2026 | 3.50% | 4.30 | |
| 14 Aug 2026 | 2.88% | 4.05 | 10-Q filed, results (8-K) |
| 31 Aug 2026 | 2.66% | 2.78 | |
| 15 Sep 2026 | 2.81% | 4.94 |
See also: Acrivon Therapeutics, Inc.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.